Article
Biochemical investigations in patients with dementia.
Annals of clinical biochemistry - 1 May 2002
Green Alison
Abstract excerpt
The recent development of acetylcholinesterase inhibitors to treat patients with Alzheimer's disease has increased interest in the use of biochemical markers for the early detection and diagnosis of dementia, but only the measurement of the protein 14-3-3 in cerebrospinal fluid (CSF) to help diagnose sporadic Creutzfeldt-Jakob disease has become accepted clinical practice. CSF concentrations of tau protein and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
